NHS Kingston
Home > 8 Malignant disease and immunosuppression > 8.2 Drugs affecting the immune response > 8.2.4 Other immunomodulating drugs > Multiple sclerosis (relapsing) - teriflunomide NICE TAG TA303

Multiple sclerosis (relapsing) - teriflunomide NICE TAG TA303

Teriflunomide is recommended for treating adults with active relapsing–remitting multiple sclerosis (normally defined as 2 clinically significant relapses in the previous 2 years), only if

they do not have highly active or rapidly evolving severe relapsing–remitting multiple sclerosis and

the manufacturer provides teriflunomide with the discount agreed in the patient access scheme.


Site by Devopa
© Copyright 2023 NHS. All rights reserved.